Literature DB >> 7055434

Generalized peritonitis. To irrigate or not to irrigate the abdominal cavity.

J L Hunt.   

Abstract

The objectives of surgery for generalized peritonitis are to eliminate the source of continual bacterial contamination and to prevent septicemia and intra-abdominal abscess formation. A prospective randomized study of three different operative approaches of treating residual peritoneal contamination was undertaken: group 1, no peritoneal irrigation (14 patients); group 2, intraoperative peritoneal irrigation (15 patients); group 3, both intraoperative and postoperative peritoneal irrigation (15 patients). The mortality in groups 1, 2, and 3 was 28.5%, 26.6%, and 33%, respectively. The overall incidence of septicemia and intra-abdominal abscesses in groups 1, 2, and 3 was 23%, 22%, and 17%, respectively. In those patients who survived, the incidence of intra-abdominal abscesses, wound infection, and septicemia was 6%, 23%, and 13%, respectively. In this series, there was no detectable difference in the mortality and infectious complications between the three treatment groups. The only clinical factors that adversely affected mortality and morbidity were peritonitis originating from the colon and age greater than 60 years. Early surgical intervention with removal of the source of peritonitis, debridement of all necrotic tissue, and drainage of abscesses remain the cornerstones of successful therapy in generalized peritonitis.

Entities:  

Mesh:

Year:  1982        PMID: 7055434     DOI: 10.1001/archsurg.1982.01380260075013

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

1.  Treatment strategy when using intraoperative peritoneal lavage for perforated appendicitis in children: a preliminary report.

Authors:  Yasuharu Ohno; Junichiro Furui; Takashi Kanematsu
Journal:  Pediatr Surg Int       Date:  2004-06-16       Impact factor: 1.827

Review 2.  Intracavity lavage and wound irrigation for prevention of surgical site infection.

Authors:  Gill Norman; Ross A Atkinson; Tanya A Smith; Ceri Rowlands; Amber D Rithalia; Emma J Crosbie; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

3.  [Relaparotomy following stomach operations].

Authors:  F Schulz; R Függer; J Polcik
Journal:  Langenbecks Arch Chir       Date:  1984

Review 4.  Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intraabdominal infection. Joint Working Party of SIS North America and Europe.

Authors:  P O Nyström; R Bax; E P Dellinger; L Dominioni; W A Knaus; J L Meakins; C Ohmann; J S Solomkin; H Wacha; D H Wittmann
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

5.  Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis.

Authors:  A K May; T G Gleason; R G Sawyer; T L Pruett
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

6.  Enhanced virulence of Escherichia coli bearing a site-targeted mutation in the major structural subunit of type 1 fimbriae.

Authors:  A K May; C A Bloch; R G Sawyer; M D Spengler; T L Pruett
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Increased postoperative peritoneal adhesion formation after the treatment of experimental peritonitis with chlorhexidine.

Authors:  Almantas Maleckas; Virmantas Daubaras; Valdas Vaitkus; Albina Aniuliene; Evaldas Dirzinauskas; Mindaugas Rakauskas; Juozas Pundzius
Journal:  Langenbecks Arch Surg       Date:  2004-05-25       Impact factor: 3.445

8.  Meta-analysis of peritoneal lavage in appendicectomy.

Authors:  E Gammeri; T Petrinic; G Bond-Smith; A Gordon-Weeks
Journal:  BJS Open       Date:  2018-11-29

9.  A Randomized Controlled Trial on Intra-Abdominal Irrigation during Emergency Trauma Laparotomy; Time for Yet Another Paradigm Shift.

Authors:  Hassan Mashbari; Mohannad Hemdi; Kevin L Chow; James C Doherty; Gary J Merlotti; Steven L Salzman; Eduardo Smith Singares
Journal:  Bull Emerg Trauma       Date:  2018-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.